Optiver Holding’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.24K Buy
82
+12
+17% +$833 ﹤0.01% 1400
2025
Q4
$5.56K Sell
70
-124
-64% -$10.5K ﹤0.01% 1315
2025
Q3
$12.8K Buy
+194
New +$11.5K ﹤0.01% 1150

Other funds holding IRON

Optiver Holding's IRON Position: Q1 2026 in Review

Optiver Holding increased its Disc Medicine (IRON) stake by 17% in Q1 2026, buying an estimated $833 and bringing the position to 82 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Optiver Holding first reported a position in IRON in Q3 2025 and has held it in 3 quarters since. The position peaked at $12.8K in Q3 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Optiver Holding held 82 shares of Disc Medicine worth $5.24K as of Q1 2026.
  • Optiver Holding bought 12 Disc Medicine shares in Q1 2026, an estimated $833.
  • Disc Medicine made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1400 holding.
  • Optiver Holding first reported a position in Disc Medicine in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Disc Medicine position peaked at $12.8K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.